ATER News and Press, Aterian Inc. From 12/08/21

Energy Focus (NASDAQ:EFOI) +52% launches nUVo virus-targeted UVC air disinfectors to public. Lexaria Bioscience (NASDAQ:LEXX) +25% dehydraTECHTM-CBD reduces arterial stiffness, results confirmed in human clinical study HYPER-H21-2. Dare Bioscience (NASDAQ:DARE) +23% announces F...

Shares of Aterian (NASDAQ: ATER) tanked 23.6% in November, according to data from S&P Global Market Intelligence . The consumer products roll-up reported another disappointing earnings result, and its founder and chief executive officer, Yaniv Sarig, continues to post strang...

In early 2021, e-commerce company Aterian (NASDAQ: ATER) was flying high. Aterian had leveraged its artificial intelligence and data gathering algorithms to quickly and effectively produce and bring to market products to sell on websites like Amazon . Shares reached a high ...

ATER’s tech-enabled CPG platform has its merits, even as e-commerce penetration deepens within the retail space. ATER’s supply chain woes are more pronounced than peers given the nature of the products that it sells. ATER financing arrangements are sub-optimal and th...

NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it ranked 303 rd on Deloitte’s 2021 Technology Fast 500™, a ranking of the 500 fastest growing —public and private— technology, media, tele...

Although Q3 2021 results came in above consensus on revenues and operating profit, we believe the overall picture on Aterian has not changed materially, and the outlook remains gloomy. Q3 net revenues reached $68.1 mln (+16% YoY), of which $35.4 mln were supported by organic business ...

Shares of Aterian (NASDAQ: ATER) are making big gains on Tuesday. The company's share price was up roughly 14.5% today as of 11:30 a.m. EST. Aterian published third-quarter results after the market closed yesterday, posting better-than-expected sales for the period and setting u...

Aterian (NASDAQ:ATER) reported Q3 beat with revenue up 16% on the year to $68.12, compared to the consensus of $63.03M. Net loss was $(110.6)M, including a $(107.0)M loss from extinguishment of debt, a $8.1M gain from the change in fair value of warrants, and a $(1.4)M gain associated with a ...

Aterian, Inc. (ATER) Q3 2021 Results Conference Call November 08, 2021 05:00 PM ET Company Participants Ilya Grozovsky - Director of IR & Corporate Development Yaniv Sarig - Co-Founder, President, CEO & Chairman Arturo Rodriguez - CFO Conference Call Participants Brian Nagel - Oppenhe...

Aterian (NASDAQ:ATER): Q3 EPS of -$3.13 may not be comparable to consensus of -$0.17. Revenue of $68.12M (+15.9% Y/Y) beats by $5.09M. Press Release For further details see: Aterian EPS of -$3.13